Yokel R A, McNamara P J
Toxicol Appl Pharmacol. 1985 Feb;77(2):344-52. doi: 10.1016/0041-008x(85)90334-5.
Prolonged aluminum (Al) exposure produces neurobehavioral and skeletal toxicity. To further characterize the risk from Al exposure, lactating rabbits were administered iv (40 or 80 mumol/kg), po (4 or 20 mmol/kg), and sc (400 mumol/kg) doses of Al lactate on Days 10, 15, and 20 of lactation. Baseline pretreatment Al concentration averaged 138 ng/ml in serum and 710 ng/ml in milk. Individual baseline values were subtracted from posttreatment samples, and pharmacokinetic analysis was performed on these residual values. The high and low doses did not produce statistically significant differences in systemic clearance, half-life, or the apparent volume of distribution. The amount of aluminum in milk 24 hr after injection was estimated to be 2.4% of the iv and 3.3% of the absorbed sc dose. Systemic bioavailability of Al after low- (0.7 +/- 0.5% means +/- SD) and high-dose po Al (1.9 +/- 1.7%) was not significantly different. Bioavailability of sc Al was 27 +/- 7%. Rabbits receiving daily sc Al injections (400 mumol/kg) for 28 consecutive days demonstrated nonlinear kinetics. Preinjection serum Al concentrations and the area under the curves associated with the 7th dose were considerably greater than with the 1st dose. Further increases were seen with the 28th dose. Seven days after the last Al injection, 12% of the total Al injected was still in the region of the injections, indicating prolonged absorption. The bioavailability and disposition of Al were determined in 17- to 24-day old suckling rabbit offspring after iv (40 mumol/kg) and po (4 mmol/kg in water or milk) doses of Al lactate. Baseline pretreatment serum Al concentration averaged 119 ng/ml. Mean systemic clearance was comparable in offspring and adults, although the apparent volume of distribution was greater in offspring producing a longer half-life in the offspring. The limited distribution of Al into milk and poor GI absorption of Al support the observation that there is little risk of Al toxicity in suckling offspring of Al exposed nursing females.
长期接触铝(Al)会产生神经行为毒性和骨骼毒性。为了进一步明确铝暴露的风险,在哺乳期第10、15和20天,给哺乳的兔子静脉注射(40或80 μmol/kg)、口服(4或20 mmol/kg)和皮下注射(400 μmol/kg)乳酸铝。基线预处理时,血清铝浓度平均为138 ng/ml,乳汁中为710 ng/ml。从治疗后的样本中减去个体基线值,并对这些残差值进行药代动力学分析。高剂量和低剂量在全身清除率、半衰期或表观分布容积方面未产生统计学上的显著差异。注射后24小时乳汁中的铝含量估计为静脉注射剂量的2.4%和皮下吸收剂量的3.3%。低剂量(0.7±0.5%,均值±标准差)和高剂量口服铝(1.9±1.7%)后的全身生物利用度无显著差异。皮下注射铝的生物利用度为27±7%。连续28天每天接受皮下注射铝(400 μmol/kg)的兔子表现出非线性动力学。注射前血清铝浓度以及与第7剂相关的曲线下面积明显大于第1剂。第28剂时进一步升高。最后一次铝注射7天后,注射的总铝量的12%仍在注射部位,表明吸收延长。在给17至24日龄的哺乳兔后代静脉注射(40 μmol/kg)和口服(水中或乳汁中4 mmol/kg)乳酸铝后,测定了铝的生物利用度和处置情况。基线预处理时血清铝浓度平均为119 ng/ml。后代和成年动物的平均全身清除率相当,尽管后代的表观分布容积更大,导致半衰期更长。铝在乳汁中的分布有限以及铝在胃肠道的吸收较差,支持了以下观察结果:暴露于铝的哺乳雌性动物的哺乳后代中铝中毒风险很小。